Search results
Results from the WOW.Com Content Network
Premenstrual dysphoric disorder, or PMDD, can cause mood swings before your period. Doctors share remedies to treat the disorder. PMDD treatment: Doctors share remedies and medications that may ...
Sertraline, sold under the brand name Zoloft among others, is an antidepressant medication of the selective serotonin reuptake inhibitor (SSRI) class [10] used to treat major depressive disorder, generalized anxiety disorder, social anxiety disorder, obsessive–compulsive disorder (OCD), panic disorder, and premenstrual dysphoric disorder. [11]
To receive a diagnosis of PMDD, Langdon says a woman must meet five separate criteria: First, during the two weeks before a woman’s period starts, symptoms must include severe anxiety or tension ...
Clinicians consider mood symptoms, physical symptoms and impact on the patient's life in making the diagnosis of PMDD. Mood symptoms include emotional lability (rapidly changing emotions, sensitivity to rejection, etc.), irritability and anger that may lead to conflict, anxiety, feeling on edge, hopelessness, difficulty concentrating, appetite changes, sleeping more or less than usual, or ...
1 in 3 women with premenstrual dysphoric disorder (PMDD) will attempt to take their own lives, and 72% experience suicidal ideation. Amanda L., 28, knows these statistics all too well.
Some supporters of PMS as a social construct believe PMDD and PMS to be unrelated issues: according to them, PMDD is a product of brain chemistry, and PMS is a product of culture, i.e. a culture-bound syndrome. Women are socially conditioned to expect PMS, or to at least know of its existence, and they therefore report their symptoms accordingly.
These are the most common antidepressants prescribed to patients: Selective serotonin reuptake inhibitors (SSRIs) Serotonin and norepinephrine reuptake inhibitors (SNRIs) Tricyclic antidepressants ...
The study authors' note: "emotional blunting is reported by nearly half of depressed patients on antidepressants and that it appears to be common to all monoaminergic antidepressants not only SSRIs". Additionally, they note: "The OQuESA scores are highly correlated with the HAD depression score; emotional blunting cannot be described simply as ...